Evidence map›Paper›PMID 24820942›Full record

ReviewThe journal of ECT2014

Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy.

Shawn M McClintock, Jimmy Choi, Zhi-De Deng, Lawrence G Appelbaum, Andrew D Krystal, Sarah H Lisanby

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in The journal of ECT, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03863925 (Comparison of Propofol Target-Controlled Infusion Anesthesia and Bolus Injection in Electroconvulsive Therapy), which is not on this map. Cited by 49 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 4 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03863925 phase4completednot on this mapstarted 2017, after this paper: background citation

Comparison of Propofol Target-Controlled Infusion Anesthesia and Bolus Injection in Electroconvulsive Therapy: A Randomized Controlled Trial

TypeinterventionalSponsorChang Gung Memorial HospitalRan2017 to 2019Enrolled40ConditionsDepression, Schizophrenia, Bipolar Disorder, Cognitive DysfunctionArmsTarget controlled infusion, Schnider model, Bolus injection of Propofol
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 4 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2022
    Trial
  7. Electroconvulsive Therapy Pulse Amplitude and Clinical Outcomes.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2021
    Trial
  8. Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2020
    Trial
  9. Trial
  10. Effect of ECT-anesthetics on reorientation time.European archives of psychiatry and clinical neuroscience · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Electroconvulsive therapy and autobiographical memory.Psychiatry, psychology, and law : an interdisciplinary journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law · 2026
    Article
  17. Article
  18. Article
  19. Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shawn M McClintockFrom the *Division of Brain Stimulation and Neurophysiology, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC; †Department of Psychology and Neuroscience, Duke University, Durham, NC; ‡Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX and §Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, New York, NY.
Jimmy Choi
Zhi-De Deng
Lawrence G Appelbaum
Andrew D Krystal
Sarah H Lisanby
Duke University · USColumbia University · US

Funding

Intrinsic Motivation and Learning in SchizophreniaK23MH086755 · NIMH · HARTFORD HOSPITAL · PI CHOI, JIMMY · 2011 to 2015
$895k
Translational Research Evaluating Neurocognitive Memory Processes (TREC-MP)K23MH087739 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI MCCLINTOCK, SHAWN M · 2010 to 2014
$641k
NIMH NIH HHS K23 MH086755NIMH NIH HHS K23 MH087739
6 · The paper itself

Abstract

For many patients with neuropsychiatric illnesses, standard psychiatric treatments with mono or combination pharmacotherapy, psychotherapy, and transcranial magnetic stimulation are ineffective. For these patients with treatment-resistant neuropsychiatric illnesses, a main therapeutic option is electroconvulsive therapy (ECT). Decades of research have found ECT to be highly effective; however, it can also result in adverse neurocognitive effects. Specifically, ECT results in disorientation after each session, anterograde amnesia for recently learned information, and retrograde amnesia for previously learned information. Unfortunately, the neurocognitive effects and underlying mechanisms of action of ECT remain poorly understood. The purpose of this paper was to synthesize the multiple moderating and mediating factors that are thought to underlie the neurocognitive effects of ECT into a coherent model. Such factors include demographic and neuropsychological characteristics, neuropsychiatric symptoms, ECT technical parameters, and ECT-associated neurophysiological changes. Future research is warranted to evaluate and test this model, so that these findings may support the development of more refined clinical seizure therapy delivery approaches and efficacious cognitive remediation strategies to improve the use of this important and widely used intervention tool for neuropsychiatric diseases.

Indexed as

Cognition DisordersElectroconvulsive TherapyHumansMental DisordersNeuropsychological TestsRisk Factors

Identifiers

PMID24820942
PMCPMC4143898
OpenAlexW2073920244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.